Work in preclinical models of cancer have solidified the importance of HO-1, in some TMEs, to be pivotal to immune suppression which prevents efficient anti-tumor immunity as HO-1 activity suppresses T-cell effector function (2, 26). This evidence concerns the gene HMOX1 and cancer.